Research programme: conjugated vaccines - SutroVax
Latest Information Update: 27 Jul 2015
At a glance
- Originator SutroVax
- Class Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Infections
Most Recent Events
- 08 Jan 2014 Early research in Infections in USA (Parenteral)